Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.75 TWD
165.83 M TWD
622.12 M TWD
65.78 M
About MAXIGEN BIOTECH INC
Sector
Industry
CEO
Jing Ting Chen
Website
Headquarters
Taoyuan
Founded
1998
ISIN
TW0001783009
FIGI
BBG001P17QS2
Maxigen Biotech, Inc. engages in the business of collagen purification; research and development, production, and selling implantable medical device; and producing, manufacturing, wholesaling, and retailing cosmetics. It operates through the following segments: Biomedical Products, Consumer Products, and Others. The Biomedical Products segment includes manufacturing and selling collagen and bone materials. The Consumer Products segment focuses on beauty care products. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1783 is 48.65 TWD — it hasn't changed in the past 24 hours. Watch MAXIGEN BIOTECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange MAXIGEN BIOTECH INC stocks are traded under the ticker 1783.
1783 stock has risen by 1.19% compared to the previous week, the month change is a 5.39% rise, over the last year MAXIGEN BIOTECH INC has showed a 0.31% increase.
1783 reached its all-time high on May 5, 2023 with the price of 71.45 TWD, and its all-time low was 10.90 TWD and was reached on Mar 23, 2020. View more price dynamics on 1783 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1783 stock is 4.26% volatile and has beta coefficient of 0.42. Track MAXIGEN BIOTECH INC stock price on the chart and check out the list of the most volatile stocks — is MAXIGEN BIOTECH INC there?
Today MAXIGEN BIOTECH INC has the market capitalization of 4.18 B, it has increased by 1.30% over the last week.
Yes, you can track MAXIGEN BIOTECH INC financials in yearly and quarterly reports right on TradingView.
MAXIGEN BIOTECH INC is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
1783 net income for the last quarter is 49.52 M TWD, while the quarter before that showed 59.73 M TWD of net income which accounts for −17.09% change. Track more MAXIGEN BIOTECH INC financial stats to get the full picture.
Yes, 1783 dividends are paid annually. The last dividend per share was 1.00 TWD. As of today, Dividend Yield (TTM)% is 2.13%. Tracking MAXIGEN BIOTECH INC dividends might help you take more informed decisions.
MAXIGEN BIOTECH INC dividend yield was 2.06% in 2023, and payout ratio reached 53.56%. The year before the numbers were 1.05% and 30.38% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 27, 2024, the company has 131.00 employees. See our rating of the largest employees — is MAXIGEN BIOTECH INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MAXIGEN BIOTECH INC EBITDA is 175.85 M TWD, and current EBITDA margin is 28.52%. See more stats in MAXIGEN BIOTECH INC financial statements.
Like other stocks, 1783 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MAXIGEN BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MAXIGEN BIOTECH INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MAXIGEN BIOTECH INC stock shows the buy signal. See more of MAXIGEN BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.